Genentech/Curis Hedgehog Inhibitor Gets Unclear Results In Ovarian Cancer Maintenance Study

Genentech/Roche will continue to follow data on GDC-0449 in the indication in light of signals that "warrant further investigation" and make a decision in coming months.